LPI (LP Information)' newest research report, the “DTaP Vaccine Industry Forecast” looks at past sales and reviews total world DTaP Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected DTaP Vaccine sales for 2023 through 2029. With DTaP Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DTaP Vaccine industry.
This Insight Report provides a comprehensive analysis of the global DTaP Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DTaP Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DTaP Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DTaP Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DTaP Vaccine.
The global DTaP Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key DTaP Vaccine players cover GlaxoSmithKline, Sanofi Pasteur, Ltd. and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of DTaP Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application
Government Institution
Private Sector
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Sanofi Pasteur, Ltd.
Merck
Key Questions Addressed in this Report
What is the 10-year outlook for the global DTaP Vaccine market?
What factors are driving DTaP Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DTaP Vaccine market opportunities vary by end market size?
How does DTaP Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global DTaP Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for DTaP Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for DTaP Vaccine by Country/Region, 2018, 2022 & 2029 2.2 DTaP Vaccine Segment by Type 2.2.1 Inactivated Vaccine 2.2.2 Live Attenuated Vaccine 2.3 DTaP Vaccine Sales by Type 2.3.1 Global DTaP Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global DTaP Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global DTaP Vaccine Sale Price by Type (2018-2023) 2.4 DTaP Vaccine Segment by Application 2.4.1 Government Institution 2.4.2 Private Sector 2.4.3 Other 2.5 DTaP Vaccine Sales by Application 2.5.1 Global DTaP Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global DTaP Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global DTaP Vaccine Sale Price by Application (2018-2023) 3 Global DTaP Vaccine by Company 3.1 Global DTaP Vaccine Breakdown Data by Company 3.1.1 Global DTaP Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global DTaP Vaccine Sales Market Share by Company (2018-2023) 3.2 Global DTaP Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global DTaP Vaccine Revenue by Company (2018-2023) 3.2.2 Global DTaP Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global DTaP Vaccine Sale Price by Company 3.4 Key Manufacturers DTaP Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers DTaP Vaccine Product Location Distribution 3.4.2 Players DTaP Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for DTaP Vaccine by Geographic Region 4.1 World Historic DTaP Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global DTaP Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global DTaP Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic DTaP Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global DTaP Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global DTaP Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas DTaP Vaccine Sales Growth 4.4 APAC DTaP Vaccine Sales Growth 4.5 Europe DTaP Vaccine Sales Growth 4.6 Middle East & Africa DTaP Vaccine Sales Growth 5 Americas 5.1 Americas DTaP Vaccine Sales by Country 5.1.1 Americas DTaP Vaccine Sales by Country (2018-2023) 5.1.2 Americas DTaP Vaccine Revenue by Country (2018-2023) 5.2 Americas DTaP Vaccine Sales by Type 5.3 Americas DTaP Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC DTaP Vaccine Sales by Region 6.1.1 APAC DTaP Vaccine Sales by Region (2018-2023) 6.1.2 APAC DTaP Vaccine Revenue by Region (2018-2023) 6.2 APAC DTaP Vaccine Sales by Type 6.3 APAC DTaP Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe DTaP Vaccine by Country 7.1.1 Europe DTaP Vaccine Sales by Country (2018-2023) 7.1.2 Europe DTaP Vaccine Revenue by Country (2018-2023) 7.2 Europe DTaP Vaccine Sales by Type 7.3 Europe DTaP Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa DTaP Vaccine by Country 8.1.1 Middle East & Africa DTaP Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa DTaP Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa DTaP Vaccine Sales by Type 8.3 Middle East & Africa DTaP Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of DTaP Vaccine 10.3 Manufacturing Process Analysis of DTaP Vaccine 10.4 Industry Chain Structure of DTaP Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 DTaP Vaccine Distributors 11.3 DTaP Vaccine Customer 12 World Forecast Review for DTaP Vaccine by Geographic Region 12.1 Global DTaP Vaccine Market Size Forecast by Region 12.1.1 Global DTaP Vaccine Forecast by Region (2024-2029) 12.1.2 Global DTaP Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global DTaP Vaccine Forecast by Type 12.7 Global DTaP Vaccine Forecast by Application 13 Key Players Analysis 13.1 GlaxoSmithKline 13.1.1 GlaxoSmithKline Company Information 13.1.2 GlaxoSmithKline DTaP Vaccine Product Portfolios and Specifications 13.1.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 GlaxoSmithKline Main Business Overview 13.1.5 GlaxoSmithKline Latest Developments 13.2 Sanofi Pasteur, Ltd. 13.2.1 Sanofi Pasteur, Ltd. Company Information 13.2.2 Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolios and Specifications 13.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sanofi Pasteur, Ltd. Main Business Overview 13.2.5 Sanofi Pasteur, Ltd. Latest Developments 13.3 Merck 13.3.1 Merck Company Information 13.3.2 Merck DTaP Vaccine Product Portfolios and Specifications 13.3.3 Merck DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Merck Main Business Overview 13.3.5 Merck Latest Developments 14 Research Findings and Conclusion